Dr. Dirk Ullmann

Angestellt, Global Head Drug Discovery Services and Managing Director Evotec (München) GmbH, Evotec AG

Neuried, Germany


Drug Discovery Expertise
Assay Development
High-throughput Screening
Data Management
Structural Biology
Detection Technology
Leadership Expertise
Project Management Track Record
Industrial and Academic Network
Compound Management
Protein chemistry


Professional experience for Dirk Ullmann

  • Current 5 years and 5 months, since Jan 2018

    Global Head Drug Discovery Services and Managing Director Evotec (München) GmbH

    Evotec AG

    Global Responsibilities for HitID by HT Technologies, Biophysics etc., Protein and Cellular Sciences, Structural Biology, Compound Management, ADME-tox/DMPK and Proteomics.

  • Current 11 years and 9 months, since Sep 2011

    Executive Vice President Lead Discovery, Managing Director Evotec (München) GmbH

    Evotec AG

    Responsibilities for Proteomics, Structural biology, Biophysics incl. NMR, Biochemical Assays, Screening Operations: Processes: Hit ID, Fragment ID, Hit Triaging, Protein Production, Structural Biology and Structure-Based Drug Design (SBDD), Technology Scouting and Development

  • 2 years and 8 months, Jan 2009 - Aug 2011

    Chief Scientific Officer (CSO)

    Proteros biostructures GmbH

  • 2 years, Jan 2007 - Dec 2008

    Senior Vice President Discovery Biology

    Evotec AG

  • 4 years and 8 months, May 2002 - Dec 2006

    Director Biology Services

    Evotec AG

  • 2 years and 5 months, Dec 1999 - Apr 2002

    Head of Screening Operations

    Evotec AG

  • 1 year and 3 months, Oct 1998 - Dec 1999

    Section Head Assay Development

    Evotec Biosystems AG

  • 1 year and 1 month, Sep 1997 - Sep 1998

    Research Scientist New Technologies Physics

    Evotec Biosystems

Educational background for Dirk Ullmann

  • 1995 - 1997

    Protein Engineering

    Brandeis University (Waltham, MA, USA)

    Supervisors: Prof. Dr. Lizbeth K. Hedstrom; Prof. Dr. Robert H. Abeles Performed site-directed mutagenesis to explore the structural features which determine the S’ subsite specificity of serine proteases and its proenzymes.

  • 1992 - 1997

    Scientific Assistant

    University of Leipzig

    - Design of proteases and zymogens as new biocatalysts in peptide and protein synthesis - Directed evolution of proteases as restriction proteases and peptide ligases - Conversion of enzyme specificity by protein and substrate engineering - Construction of „substrate mimetics“

  • 2 months, Sep 1991 - Oct 1991

    Institute of Science and technology

    Universit y of Manchester

  • 1991 - 1994


    University of Leipzig

    Solid phase synthesis of a pentapeptide library and their use to explore the S’ subsite specificity of the cysteine protease clostripain

  • 1990 - 1991

    Inorganic Chemistry

    University of Leipzig

    Investigations on the reactivity of dithiocarboxyesters with nucleophiles. Functionalization to derivatives with ligand properties and synthesis of metal complexes.


  • German

    First language

  • English


  • Russian



Business contacts
Scientific community
Academic partners
impact modern drug discovery process


Drug Discovery
Structural Biology
Protein Chemistry
Molecular Evolution
Medicinal Chemistry
Structure-guided drug discovery

Browse over 20 million XING members